Can-Fite BioPharma CANF
NYSE CANF
$2.21 +0.03 (+1.61%)
As of: Sep 30, 2026 · 3:58 PM EDT

Can-Fite BioPharma (CANF) EPS (Basic) (2016 - 2023)

Updated

Can-Fite BioPharma (CANF) posted EPS (Basic) of -$11.94 for FY2025, compared with -$0.14 in FY2024.

Analysis

Can-Fite BioPharma (CANF) EPS (Basic) (2016 - 2023) Analysis & Trends

Since FY2016, Can-Fite BioPharma has reported EPS (Basic) for 10 years.

  • The FY2025 figure stands as the lowest annual EPS (Basic) in data going back to FY2016.
  • Business Quant data shows CANF's EPS (Basic) at -$0.14 in FY2024, -$0.24 in FY2023, -$0.37 in FY2022 and -$0.73 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 2.30
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 2.04
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -0.54
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 1.68
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 1.87
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 4.40
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -8.44
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -0.04
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 4.34
10 Can-Fite BioPharma 1.82 Mn -17.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -0.05
Sep 30, 2023 -0.09
Jun 30, 2023 0.12
Mar 31, 2023 -0.13
Dec 31, 2022 -0.02
Sep 30, 2022 -0.18
Jun 30, 2022 0.18
Mar 31, 2022 -0.18
Dec 31, 2021 -0.30
Sep 30, 2021 -0.38
Jun 30, 2021 -0.36
Mar 31, 2021 -0.21
Dec 31, 2020 -0.41
Sep 30, 2020 -1.20
Jun 30, 2020 -1.81
Dec 31, 2019 -0.81
Sep 30, 2019 -3.03
Jun 30, 2019 -6.91
Mar 31, 2019 1.88
Dec 31, 2018 -9.99
API Access

Can-Fite BioPharma EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=CANF&period=max&api_key=YOUR_API_KEY